115 related articles for article (PubMed ID: 34473934)
1. Role of cerebrospinal fluid tau protein levels as a biomarker of brain injury in pediatric status epilepticus.
Sood S; Azad C; Kaur J; Kumar P; Guglani V; Singla S
Int J Neurosci; 2023 Jul; 133(7):782-790. PubMed ID: 34473934
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid tau proteins in status epilepticus.
Monti G; Tondelli M; Giovannini G; Bedin R; Nichelli PF; Trenti T; Meletti S; Chiari A
Epilepsy Behav; 2015 Aug; 49():150-4. PubMed ID: 25958230
[TBL] [Abstract][Full Text] [Related]
3. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.
Shahim P; Rejdak R; Ksiazek P; Blennow K; Zetterberg H; Mattsson N; Rejdak K
Eur J Neurol; 2014 Mar; 21(3):486-91. PubMed ID: 24372994
[TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus.
Giovannini G; Bedin R; Ferraro D; Vaudano AE; Mandrioli J; Meletti S
Epilepsia; 2022 Jan; 63(1):e23-e29. PubMed ID: 34806176
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
Irwin DJ; Fedler J; Coffey CS; Caspell-Garcia C; Kang JH; Simuni T; Foroud T; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Weintraub D; Mollenhauer B; Galasko DR; Siderowf A; Marek K; Trojanowski JQ; Shaw LM;
Ann Neurol; 2020 Sep; 88(3):574-587. PubMed ID: 32542885
[TBL] [Abstract][Full Text] [Related]
7. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.
Almeida RP; Schultz SA; Austin BP; Boots EA; Dowling NM; Gleason CE; Bendlin BB; Sager MA; Hermann BP; Zetterberg H; Carlsson CM; Johnson SC; Asthana S; Okonkwo OC
JAMA Neurol; 2015 Jun; 72(6):699-706. PubMed ID: 25893879
[TBL] [Abstract][Full Text] [Related]
9. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease.
Llibre-Guerra JJ; Li Y; Schindler SE; Gordon BA; Fagan AM; Morris JC; Benzinger TLS; Hassenstab J; Wang G; Allegri R; Berman SB; Chhatwal J; Farlow MR; Holtzman DM; Jucker M; Levin J; Noble JM; Salloway S; Schofield P; Karch C; Fox NC; Xiong C; Bateman RJ; McDade E
JAMA Netw Open; 2019 Dec; 2(12):e1917126. PubMed ID: 31825500
[TBL] [Abstract][Full Text] [Related]
10. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.
Morris JC; Schindler SE; McCue LM; Moulder KL; Benzinger TLS; Cruchaga C; Fagan AM; Grant E; Gordon BA; Holtzman DM; Xiong C
JAMA Neurol; 2019 Mar; 76(3):264-273. PubMed ID: 30615028
[TBL] [Abstract][Full Text] [Related]
12. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
13. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
[TBL] [Abstract][Full Text] [Related]
15. Adult convulsive status epileptic us: clinical, etiological, and predictors of outcome study from rural population of North India.
Verma A; Kiran K; Vaishya GP; Kumar A
Int J Neurosci; 2019 Jun; 129(6):573-579. PubMed ID: 30475096
[TBL] [Abstract][Full Text] [Related]
16. The etiology and prognosis of super-refractory convulsive status epilepticus in children.
Lu WY; Weng WC; Wong LC; Lee WT
Epilepsy Behav; 2018 Sep; 86():66-71. PubMed ID: 30006260
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment.
Garrett SL; McDaniel D; Obideen M; Trammell AR; Shaw LM; Goldstein FC; Hajjar I
JAMA Netw Open; 2019 Dec; 2(12):e1917363. PubMed ID: 31834392
[TBL] [Abstract][Full Text] [Related]
18. Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden.
Grøntvedt GR; Sando SB; Lauridsen C; Bråthen G; White LR; Salvesen Ø; Aarsland D; Hessen E; Fladby T; Waterloo K; Scheffler K
JAMA Netw Open; 2022 Nov; 5(11):e2243232. PubMed ID: 36413367
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
[TBL] [Abstract][Full Text] [Related]
20. Convulsive status epilepticus: clinical profile in a developing country.
Murthy JM; Jayalaxmi SS; Kanikannan MA
Epilepsia; 2007 Dec; 48(12):2217-23. PubMed ID: 17651412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
